Concepedia

Author

Adriane Hommertgen

University Hospital Heidelberg

Also Known As

A. Hommertgen, Adriane Hommertgen

24

Publications

285

Citations

11

H-Index

11

Concepts

All Affiliations

University Hospital HeidelbergHeidelberg UniversityGerman Cancer Research CenterHeidelberger Institut für RadioonkologieNational Center for Tumor Diseases
AH

About

Adriane Hommertgen is an author at University Hospital Heidelberg specializing in radiation oncology, medicine, and radiation therapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

104

2

Adaptive Radiotherapy

2

2

74

3

Health Sciences

1

1

30

4

Radiation Medicine

1

1

57

5

Surgical Oncology

1

1

30

Adriane Hommertgen

×

12

Publications

266

Citations

11

H-Index

YearCitations

Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)

Juliane Hörner‐Rieber, Tobias Förster, Adriane Hommertgen,

International Journal of Radiation Oncology*Biology*Physics

2020

57

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Farastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam,

BMC Cancer

2019

35

Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial

Denise Bernhardt, Adriane Hommertgen, Daniela Schmitt,

Trials

2018

32

Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas

Laila König, Juliane Hörner‐Rieber, Denise Bernhardt,

Strahlentherapie und Onkologie

2018

30

Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study

Jakob Liermann, Patrick Naumann, Adriane Hommertgen,

BMC Cancer

2020

19

Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial

Tobias Förster, Adriane Hommertgen, Matthias Häfner,

Radiotherapy and Oncology

2021

17

Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial

Thomas Held, Kristin Lang, Sebastian Regnery,

Radiation Oncology

2020

15

Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial

Katharina Seidensaal, Meinhard Kieser, Adriane Hommertgen,

Trials

2021

15

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial

Nathalie Arians, Matthias Häfner, Johannes Krisam,

BMC Cancer

2020

12

Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

Jonas Kuon, Adriane Hommertgen, Johannes Krisam,

Trials

2020

12

Page 1